Folitrax 15

Folitrax 15

Original price was: ₹531.50.Current price is: ₹455.20.

Category: Tag:

Folitrax 15 Tablet is a pharmaceutical agent indicated for treating various cancers affecting different body regions. Additionally, it is employed in managing conditions such as rheumatoid arthritis, severe and persistent psoriasis, and Crohn’s disease. The mechanism of action involves inhibiting the proliferation of abnormal cells and moderating the immune response in autoimmune disorders. This medication can be prescribed alone or in conjunction with other therapeutic agents. It is crucial to adhere to your healthcare provider’s instructions regarding dosage to mitigate the risk of adverse reactions. Although benefits may not be immediately apparent and could take weeks or even months to manifest, it is important not to discontinue use unless advised by your physician. Potential adverse effects of Folitrax 15 Tablet include ulcerative stomatitis, alopecia, decreased blood cell levels, elevated liver enzymes, nausea, and gastrointestinal discomfort. Your healthcare provider might recommend folic acid to alleviate some side effects. Should these effects persist or intensify, it is vital to inform your physician, as there may be strategies to lessen their impact. Folitrax 15 Tablet may impair immune function and lead to complications related to your blood, liver, or kidneys; therefore, routine monitoring through blood tests, imaging studies, and physical evaluations may be required throughout your treatment. Prior to initiation, inform your doctor of any gastrointestinal, hepatic, or renal issues, as well as any other medications you are taking, to prevent interactions. The use of this medication is not advised during pregnancy or lactation due to potential risks to the fetus or infant. Avoiding alcohol while on this medication is also recommended to minimize the risk of liver complications.

Reviews

There are no reviews yet.

Be the first to review “Folitrax 15”

Your email address will not be published. Required fields are marked *